P3 Health Partners Inc(PIII) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
October 7 at 4:00 PM ET (Korea 10/8 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -33 | Insider Own | 50.94% | Shs Outstand | 3.9M | Perf Week | -18.18% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | -39.82% | Insider Trans | -1.33% | Shs Float | 1.9M | Perf Month | -38.36% |
| Enterprise Value | 0.38B | PEG | - | EPS next Q | -3.96 | Inst Own | 8.24% | Short Float | 1.43% | Perf Quarter | -43.86% |
| Income | -0.11B | P/S | 0.03 | EPS this Y | 83.94% | Inst Trans | 1.55% | Short Ratio | 0.84 | Perf Half Y | 101.27% |
| Sales | 1.50B | P/B | - | EPS next 5Y | 51.17% | ROA | -14.2% | Short Interest | 0.03M | Perf YTD | 58.6% |
| Book/sh | -23.59 | P/C | 1.81 | EPS past 3/5Y | 48.16% -2.64% | ROE | -168.78% | 52W High | -67.23% ($16.89) | Perf Year | -38.61% |
| Cash/sh | 3.06 | P/FCF | - | Sales past 3/5Y | 11.61% 24.33% | ROIC | -54.49% | 52W Low | 264.14% ($1.52) | Perf 3Y | -94.08% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 26.63% | Gross Margin | -0.9% | Volatility(W/M) | 6.87% 5.62% | Perf 5Y | -98.88% |
| Dividend TTM | - | EV/Sales | 0.25 | Sales Y/Y TTM | 2.81% | Oper. Margin | -9.89% | ATR (14) | 0.48 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.46 | EPS Q/Q | 89.85% | Profit Margin | -7.19% | RSI (14) | 20.86 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.46 | Sales Q/Q | 8.6% | SMA20 | -22.39% ($7.13) | Beta | 1.72 | Target Price | $18 |
| Payout | - | Debt/Eq | 1.81 | Earnings | 2026/8/10 | SMA50 | -38.38% ($8.97) | Rel Volume | 0.2 | Prev Close | $5.62 |
| Employees | 320 | LT Debt/Eq | 1.5 | EPS/Sales Surpr. | 66.75% 2.27% | SMA200 | -14.63% ($6.48) | Avg Volume(3M) | 0.03M | Price | $5.53 |
| IPO | 2021/4/6 | Option/Short | No/Yes | Trades | 150 | Volume | 6,584 | Change | -1.51% |
🩺 This is a healthcare platform company focused on Value-Based Care for U.S. seniors. It connects Medicare Advantage members with its physician network and manages them through performance-based contracts. It is a small-cap healthcare stock positioned to reach an inflection point in improving results.
Over the past 1 year, roughly in the middle
67% below its 1-year high.
Traded less than usual That is 20% of its average volume.
PIII has weak earnings and a weak balance sheet
Of every $100 in sales, $9.89 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +83.9% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $3. Peers typically go for $86.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -98.9%. The S&P 500 did +77% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 8.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #41 of 48 in the industry
Based on market cap of $40M.
PARK#40 Park Dental Partners Inc $100M PER - PIII#41 P3 Health Partners Inc $40M PER - 
BTMD#42 biote Corp $40M PER 9.2 
DCGO#43 DocGo Inc $34M PER - 
CCEL#44 Cryo-Cell International Inc $32M PER - 
FAQ
What kind of company is PIII?
PIII belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of PIII?
The market cap of PIII is approximately $40M, ranking 5,021 within its sector.
What is the 52-week high and low for PIII?
PIII has recorded a 52-week high of $16.89 and a low of $1.52.
